Three Decades of β-Lactamase Inhibitors

Abraham, E. P., and E. Chain. 1940. An enzyme from bacteria able to destroy penicillin. Nature146:837.

Abraham, E. P., E. Chain, C. M. Fletcher, H. W. Florey, A. D. Gardner, N. G. Heatley, and M. A. Jennings. 1941. Further observations on penicillin. Lancetii:177.

10.1016/S0021-9258(18)49972-3

10.1128/AAC.49.10.4410-4412.2005

10.1021/bi801153j

10.1128/AAC.45.2.583-588.2001

10.1111/j.1469-0691.2007.01847.x

10.1093/jac/25.2.199

10.1128/AAC.46.11.3627-3629.2002

10.1042/bj2760269

10.1345/aph.1L016

10.1128/AAC.21.2.299

Atanasov, B. P., D. Mustafi, and M. W. Makinen. 2000. Protonation of the β-lactam nitrogen is the trigger event in the catalytic action of class A β-lactamases. Proc. Natl. Acad. Sci. U. S. A.97:3160-3165.

10.1016/j.drup.2006.05.005

10.1093/jac/45.1.105

10.1128/AAC.48.2.392-395.2004

10.1517/13543784.17.3.285

10.1007/BF01704610

Bauvois, C., and J. Wouters. 2007. Crystal structures of class C β-lactamases: mechanistic implications and perspectives in drug design, p. 145-161. In R. A. Bonomo and M. E. Tolmasky (ed.), Enzyme-mediated resistance to antibiotics: mechanisms, dissemination, and prospects for inhibition. ASM Press, Washington, DC.

10.1016/S0966-842X(00)01762-5

10.1128/AAC.46.12.3978-3980.2002

10.1042/bj2090229

Belaaouaj, A., C. Lapoumeroulie, M. M. Canica, G. Vedel, P. Nevot, R. Krishnamoorthy, and G. Paul. 1994. Nucleotide sequences of the genes coding for the TEM-like β-lactamases IRT-1 and IRT-2 (formerly called TRI-1 and TRI-2). FEMS Microbiol. Lett.120:75-80.

10.1128/AAC.37.2.153

10.1128/AAC.01677-07

10.1016/S0960-894X(99)00106-7

10.1016/S0960-894X(99)00107-9

10.1128/JCM.43.8.4168-4171.2005

10.1128/AAC.37.10.2059

10.1021/bi00398a012

10.1093/jac/dkh358

10.1128/AAC.48.1.1-14.2004

Bonomo, R. A., C. Currie-McCumber, and D. M. Shlaes. 1992. OHIO-1 β-lactamase resistant to mechanism-based inactivators. FEMS Microbiol. Lett.71:79-82.

10.1016/S0167-4838(01)00175-3

10.2741/A477

10.1016/S0378-1097(97)00013-X

Antimicrob. Agents Chemother. 2007

P1112. Abstr. 19th Eur. Congr. Clin. Microbiol. Infect. Dis. 2009

10.1128/jb.176.2.333-337.1994

10.1128/CMR.14.4.933-951.2001

10.1086/421495

10.1128/AAC.38.4.761

10.1093/jac/43.2.261

10.1021/bi00516a003

10.1021/bi00319a024

Broom, N. J. P., T. H. Farmer, N. F. Osborne, and J. W. Tyler. 1992. Studies on the mechanism of action of (5R)-(Z)-6-(1-methyl-1,2,3-triazol-4-ylmethylene) penem-3-carboxylic acid (BRL 42715), a potent inhibitor of bacterial β-lactamase. J. Chem. Soc. Chem. Commun.1992:1663-1664.

Brown, A. G. 1986. Clavulanic acid, a novel β-lactamase inhibitor—a case study in drug discovery and development. Drug Des. Deliv.1:1-21.

10.1021/bi961044g

10.2174/1568026013395524

10.1016/S0040-4020(00)00427-0

10.1021/ja963708f

10.1086/514922

10.1128/CMR.1.1.109

Bush, K. 1986. Evaluation of enzyme inhibition data in screening for new drugs. Drugs Exp. Clin. Res.12:565-576.

Bush, K., and P. A. Bradford. 2007. β-Lactamases: historical perspectives, p. 67-79. In R. A. Bonomo and M. E. Tolmasky (ed.), Enzyme-mediated resistance to antibiotics: mechanisms, dissemination, and prospects for inhibition. ASM Press, Washington, DC.

10.1128/AAC.22.3.414

10.1128/AAC.01009-09

10.1128/AAC.39.6.1211

10.1128/AAC.37.4.851

10.1016/S0891-5520(05)70255-5

10.1016/j.bcp.2005.11.012

10.1016/j.bmcl.2003.12.037

10.1016/S0960-894X(00)00098-6

10.1016/S0960-894X(99)00325-X

10.1016/S0960-894X(02)00205-6

10.1021/jm00006a022

10.2165/00003495-198733060-00003

10.1016/j.mib.2006.08.011

10.1111/j.1469-0691.2007.01849.x

10.1038/278360a0

10.1016/S1074-5521(00)00052-1

Centers for Disease Control. 1982. Global distribution of penicillinase-producing Neisseria gonorrhoeae (PPNG). MMWR Morb. Mortal. Wkly. Rep.31:1-3.

10.1093/jac/37.1.190

10.1016/S0167-4838(97)00127-1

10.1093/jac/43.4.447

10.1007/s10534-006-9060-9

10.1086/513854

10.1093/jac/36.1.267

10.1021/bi00604a025

10.1021/bi00514a035

10.1021/bi00513a005

10.1016/0022-2836(92)90472-V

10.1006/jmbi.1993.1571

10.1016/j.jmb.2005.02.010

10.1021/ja056806m

10.1021/ja042850a

Cherry, P. C., C. E. Newall, and N. S. Weston. 1978. Preparation of the 7-oxo-4-oxa-1-azabicyclo[3.2.0]hept-2-ene system and the reversible cleavage of its oxazoline ring. J. Chem. Soc. Chem. Commun.1978:469-470.

10.1128/AAC.33.9.1580

10.1021/bi992569m

10.1128/AAC.45.10.2807-2812.2001

10.1016/S0960-894X(02)00061-6

Ethylidene derivatives of tricyclic carbapenems. 2002

Evaluation of enzyme inhibitors in drug discovery. 2005

10.1016/j.jhin.2007.10.016

10.1021/bi010131s

10.1042/bj2510453

10.1021/ar0400241

10.1016/S0014-5793(01)02686-2

Danel, F., M. G. Page, and D. M. Livermore. 2007. Class D β-lactamases, p. 163-194. In R. A. Bonomo and M. E. Tolmasky (ed.), Enzyme-mediated resistance to antibiotics: mechanisms, dissemination, and prospects for inhibition. ASM Press, Washington, DC.

Antimicrob. Agents Chemother. 2007

10.1038/208239a0

10.1016/S0021-9258(19)36729-8

Abstr. 47th Intersci. Conf. Antimicrob. Agents Chemother. 2007

10.1021/ja027704o

Antimicrob. Agents Chemother. 2009

10.1128/jb.172.9.4909-4918.1990

10.1093/jac/dkp029

10.1073/pnas.87.15.5858

10.1021/bi9015988

10.1021/bi9003292

10.1128/AAC.48.11.4466-4469.2004

10.1128/AAC.00387-08

Dubus, A., P. Ledent, J. Lamotte-Brasseur, and J. M. Frere. 1996. The roles of residues Tyr150, Glu272, and His314 in class C β-lactamases. Proteins25:473-485.

Dubus, A., J. M. Wilkin, X. Raquet, S. Normark, and J. M. Frere. 1994. Catalytic mechanism of active-site serine β-lactamases: role of the conserved hydroxy group of the Lys-Thr(Ser)-Gly triad. Biochem. J.30:485-494.

10.7164/antibiotics.31.1162

10.1021/bi00541a008

10.1128/iai.12.2.404-410.1975

10.1128/AAC.00641-09

10.1021/bi9015549

10.1093/jac/dkn547

10.1128/AAC.14.3.414

10.1093/jac/dkn301

10.1042/bj3030825

10.1128/AAC.40.10.2434

10.1098/rstb.1980.0048

10.1021/bi00513a004

10.1021/bi00604a024

10.1021/cr030102i

10.2174/138920309789351967

Foulds, G., W. E. Barth, J. R. Bianchine, A. R. English, D. Girard, S. L. Hayes, M. O'Brien, and P. Somani. 1980. Pharmacokinetics of CP-45.899 and pro-drug CP-47.904 in animals and humans, p. 353-356. In J. D. Nelson and C. Grassi (ed.), Current chemotherapy and infectious disease. American Society for Microbiology, Washington DC.

10.1128/AAC.25.3.392

10.1042/bj2550123

Galleni, M., and J. M. Frere. 2007. Kinetics of β-lactamases and pencillin-binding proteins, p. 195-213. In R. A. Bonomo and M. E. Tolmasky (ed.), Enzyme-mediated resistance to antibiotics: mechanisms, dissemination, and prospects for inhibition. ASM Press, Washington, DC.

10.1128/AAC.45.3.660-663.2001

10.1016/j.bmcl.2009.02.018

10.1016/j.jmb.2004.10.070

10.1128/AAC.48.7.2347-2349.2004

F1-310. Abstr. 47th Intersci. Conf. Antimicrob. Agents Chemother. 2007

10.1128/AAC.00381-05

10.1021/ja036879a

10.1093/jac/43.1.23

Giakkoupi, P., E. Tzelepi, N. J. Legakis, and L. S. Tzouvelekis. 1998. Substitution of Arg-244 by Cys or Ser in SHV-1 and SHV-5 β-lactamases confers resistance to mechanism-based inhibitors and reduces catalytic efficiency of the enzymes. FEMS Microbiol. Lett.160:49-54.

10.1042/bj2720613

10.1586/14787210.5.3.365

10.1093/jac/45.4.467

10.1128/AAC.48.6.2043-2048.2004

10.1128/MMBR.62.4.1079-1093.1998

10.7164/antibiotics.53.1022

10.1073/pnas.241442898

10.1093/clinids/18.3.305

10.1074/jbc.272.9.5438

10.1021/bi9007963

Hanson, N. D., and C. C. Sanders. 1999. Regulation of inducible AmpC β-lactamase expression among Enterobacteriaceae. Curr. Pharm. Des.5:881-894.

10.1021/bi00301a040

10.1128/AAC.25.1.149

Hedstrom, S. A. 1984. Treatment with β-lactam antibiotics in skin and soft tissue infections. Scand. J. Infect. Dis. Suppl.42:135-142.

10.1021/jm980023c

10.1074/jbc.M306059200

10.1016/j.coph.2005.04.013

10.1074/jbc.M207271200

Antimicrob. Agents Chemother. 2007

10.1021/bi700581q

10.1021/bi035716w

10.1128/AAC.39.2.427

10.1093/jac/34.5.707

10.1128/AAC.47.1.268-273.2003

10.1128/AAC.49.8.3198-3202.2005

10.1021/ja044210d

10.1021/bi971056h

10.1016/S0014-5793(00)01102-9

10.1126/science.3107125

10.1128/AAC.48.5.1586-1592.2004

10.1185/03007998409109599

10.1093/jac/25.suppl_A.49

10.1128/AAC.00866-06

10.1021/jm9800245

10.1126/science.1167498

F1-333a. Abstr. 47th Intersci. Conf. Antimicrob. Agents Chemother. 2007

10.1016/S0167-4838(01)00164-9

10.1128/AAC.00778-06

10.1021/bi0342822

10.1128/JCM.43.10.5344-5347.2005

10.1038/289590a0

10.1021/ja00064a003

10.1021/bi00185a009

10.1128/AAC.37.11.2438

10.1042/bj2710399

10.1016/S0092-8674(00)81928-5

10.1128/CMR.00036-08

10.1128/AAC.34.5.858

10.1128/AAC.35.9.1697

10.1128/AAC.48.8.3203-3206.2004

10.1056/NEJMra041359

10.1128/AAC.47.8.2615-2618.2003

10.1128/AAC.47.5.1652-1657.2003

10.1002/prot.340160406

10.1016/0732-8893(89)90083-7

10.1111/j.1469-0691.2005.01251.x

10.1128/AAC.48.5.1630-1639.2004

10.1021/bi800833u

10.1074/jbc.C700080200

10.1021/ja808311s

10.1128/AAC.48.5.1520-1525.2004

10.1128/AAC.44.4.1004-1009.2000

10.1021/bi700300u

10.1042/bj1690197

10.1126/science.99.2579.452

10.1007/BF02185845

10.1007/BF01641355

10.1042/bj2070315

10.1128/AAC.39.12.2593

10.1093/protein/6.1.11

10.1093/clinids/7.Supplement_3.S389

10.1021/bi0022745

10.1021/bi990136d

10.1093/jac/17.suppl_C.17

10.1111/j.1365-2958.1991.tb00821.x

10.1046/j.1365-2958.1999.01150.x

10.1042/bj2790213

Lan, C. K., P. R. Hsueh, W. W. Wong, C. P. Fung, Y. T. Lau, J. Y. Yeung, G. T. Young, and C. C. Su. 2003. Association of antibiotic utilization measures and reduced incidence of infections with extended-spectrum β-lactamase-producing organisms. J. Microbiol. Immunol. Infect.36:182-186.

10.1086/514743

10.1128/AAC.43.4.902

10.1128/AAC.44.10.2709-2714.2000

10.1093/jac/49.2.367

10.1016/S0021-9258(19)47357-2

Antimicrob. Agents Chemother. 2009

10.1046/j.1469-0691.2002.00415.x

10.1021/ja9741537

10.1128/AAC.38.8.1742

10.1128/AAC.39.9.1948

10.1093/jac/45.4.433

10.1039/b802311e

10.1021/jm070866g

10.1016/S0167-4838(99)00025-4

10.1016/S0003-9861(74)80018-4

10.1128/AAC.43.4.882

10.1093/jac/41.suppl_4.25

10.1007/BF02013107

Livermore, D. M. 1993. Determinants of the activity of β-lactamase inhibitor combinations. J. Antimicrob. Chemother.31(Suppl. A):9-21.

10.1128/AAC.36.9.2046

10.1093/jac/47.3.247

Livermore, D. M., M. Akova, P. J. Wu, and Y. J. Yang. 1989. Clavulanate and β-lactamase induction. J. Antimicrob. Chemother.24(Suppl. B):23-33.

10.1093/jac/40.3.335

10.1111/j.1469-0691.2007.01858.x

10.1093/jac/dkn320

10.1021/bi00188a004

10.1128/AAC.48.12.4718-4724.2004

10.1021/bi051719s

10.1021/bi900807e

10.1021/bi900808x

Reference deleted.

10.1016/S0140-6736(87)91180-9

Martinez, J. L., M. F. Vicente, A. Delgado-Iribarren, J. C. Perez-Diaz, and F. Baquero. 1989. Small plasmids are involved in amoxicillin-clavulanate resistance in Escherichia coli. Antimicrob. Agents Chemother.33:595.

10.1128/AAC.42.1.1

10.1128/AAC.39.1.227

10.1128/jb.138.3.657-662.1979

10.1021/ja016736t

10.1016/S0969-2126(00)00534-7

10.1021/ja9609718

10.1021/ja9818001

10.1093/clinids/24.Supplement_1.S19

10.1093/jac/25.4.525

10.1128/AAC.01381-07

A1-006. Abstr. 49th Intersci. Conf. Antimicrob. Agents Chemother. 2009

Meroueh, S., J. Cha, and S. Mobashery. 2007. Inhibition of class A β-lactamases, p. 101-114. In R. A. Bonomo and M. E. Tolmasky (ed.), Enzyme-mediated resistance to antibiotics: mechanisms, dissemination, and prospects for inhibition. ASM Press, Washingtion, DC.

10.1021/ja051592u

10.1021/ja026547q

10.1021/ja0426241

10.1128/AAC.14.5.794

10.1021/ja0259640

10.1128/AAC.46.12.3991-3994.2002

10.1002/prot.340070205

10.1074/jbc.M107054200

10.1016/j.femsle.2004.11.042

10.1042/bj2530323

10.1042/bj3020001

10.1021/ja0288338

10.1074/jbc.274.36.25260

10.1021/ja9817996

10.1055/s-2007-996414

10.1093/jac/dkh347

10.1042/bj2560669

10.1128/AAC.49.4.1432-1440.2005

Naas, T., and P. Nordmann. 1999. OXA-type β-lactamases. Curr. Pharm. Des.5:865-879.

10.1111/j.1469-0691.2007.01861.x

10.1093/jac/45.3.271

10.1128/AAC.43.10.2497

10.1128/AAC.36.9.1991

10.1016/j.jmb.2007.10.036

10.1128/AAC.14.5.650

10.1126/science.8153625

10.1016/S1368-7646(98)80023-X

10.1128/AAC.34.2.337

10.1128/AAC.43.8.1895

10.1016/S1473-3099(09)70054-4

10.1128/AAC.37.5.939

10.1046/j.1469-0691.2002.00401.x

10.1128/AAC.39.8.1726

10.1021/bi034986b

10.1021/ja7111146

Reference deleted.

10.1074/jbc.M312356200

10.1016/S0022-2836(03)00210-9

10.1038/343284a0

10.1073/pnas.86.23.9094

10.1128/AAC.43.4.862

10.1128/AAC.46.12.3829-3836.2002

10.1016/j.bmc.2005.11.046

10.1038/84981

10.1074/jbc.270.2.775

10.1016/j.ijantimicag.2008.06.012

10.1074/jbc.M505333200

10.1021/bi035985m

10.1021/ja063715w

10.1038/79688

10.1074/jbc.M311669200

10.1054/drup.2000.0137

Page, M. G. 2007. Resistance mediated by penicllin-binding proteins, p. 81-99. In R. A. Bonomo and M. E. Tolmasky (ed.), Enzyme-mediated resistance to antibiotics: mechanisms, dissemination, and prospects for Inhibition. ASM Press, Washington, DC.

Page, M. G., and J. Heim. 2009. New molecules from old classes: revisiting the development of β-lactams. Drugs12:561-565.

10.1016/j.coph.2009.08.006

F1-311. Abstr. 47th Intersci. Conf. Antimicrob. Agents Chemother. 2007

P1111. Abstr. 19th Eur. Congr. Clin. Microbiol. Infect. Dis. 2009

10.1016/j.bmcl.2003.08.082

10.1128/AAC.14.2.224

10.1128/AAC.00693-09

Paterson, D. L. 2006. Resistance in gram-negative bacteria: Enterobacteriaceae. Am. J. Infect. Control34:S20-S28. (Discussion, S64-S73.)

10.1128/CMR.18.4.657-686.2005

10.1074/jbc.M806833200

10.1086/501787

10.1128/AAC.00085-08

10.1074/jbc.274.19.13242

10.1016/S0014-5793(98)01289-7

10.1128/AAC.41.1.135

10.1128/AAC.38.4.767

10.1128/AAC.46.6.1880-1886.2002

10.1021/bi8015247

10.1111/j.1198-743X.2004.00766.x

10.1016/j.coph.2007.08.003

10.1128/AAC.01464-06

10.1006/jmbi.2001.4805

10.1128/AAC.01047-08

10.1111/j.1469-0691.2007.01864.x

10.1042/bj3050033

10.1128/AAC.00163-08

10.1016/S0960-894X(01)80927-6

10.1128/AAC.46.1.1-11.2002

10.1128/AAC.33.8.1131

10.7164/antibiotics.50.350

10.1016/S1473-3099(08)70041-0

10.1021/jm0703237

10.2174/1389201023378427

10.1111/j.1469-0691.2006.01456.x

10.1111/j.1469-0691.2004.00763.x

10.1089/mdr.1995.1.35

Powers, R. A., J. Blazquez, G. S. Weston, M. I. Morosini, F. Baquero, and B. K. Shoichet. 1999. The complexed structure and antimicrobial activity of a non-β-lactam inhibitor of AmpC β-lactamase. Protein Sci.8:2330-2337.

10.1021/bi0109358

10.1016/S0969-2126(02)00799-2

10.1021/jm020002p

10.1126/science.2814513

F1-0882. Abstr. 47th Intersci. Conf. Antimicrob. Agents Chemother. 2007

10.1093/clinids/23.5.1020

10.1128/CMR.00001-07

10.1128/AAC.00218-07

10.1128/AAC.41.2.223

10.1128/AAC.40.9.2080

10.1128/AAC.11.5.852

10.1093/jac/46.3.461

10.1093/clinids/8.Supplement_5.S528

10.1074/jbc.M603878200

10.1086/533452

10.1093/clinids/23.1.118

10.1093/jac/7.3.279

10.1021/jm9601967

10.1042/bj2580205

10.1128/AAC.49.11.4443-4447.2005

10.1086/508877

10.1021/bi035054a

10.1007/BF02013586

10.1111/j.1574-6968.1999.tb08709.x

10.1016/S0960-894X(01)00148-2

10.1021/ol006256r

10.1128/AAC.32.9.1365

10.1111/j.1574-6976.2008.00105.x

10.1074/jbc.270.31.18240

10.1021/bi900448u

10.1021/bi901690r

Antimicrob. Agents Chemother. 2009

10.1016/S0924-8579(01)00351-X

10.1074/jbc.M207884200

10.1073/pnas.92.2.452

10.1128/AAC.46.8.2450-2457.2002

10.1128/AAC.45.7.2179-2180.2001

10.1128/AAC.41.6.1322

Slocombe, B., A. S. Beale, R. J. Boon, K. E. Griffin, P. J. Masters, R. Sutherland, and A. R. White. 1984. Antibacterial activity in vitro and in vivo of amoxicillin in the presence of clavulanic acid, p. 29-49. InProgress and perspectives on β-lactamase inhibition: a review of Augmentin. Custom Communications: Postgraduate Medicine, New York, NY.

10.1107/S0907444901019606

10.1128/JB.182.5.1410-1414.2000

10.1093/jac/dkp197

Antimicrob. Agents Chemother. 2009

10.1038/359700a0

10.1038/368657a0

10.1038/nsb0896-688

10.1128/AAC.32.8.1267

10.1074/jbc.M501251200

10.1021/bi0487903

10.1110/ps.0224303

10.1107/S0907444901016274

10.1021/bi990758z

10.1016/S0969-2126(01)00194-0

10.1074/jbc.273.41.26714

10.1128/AAC.21.1.85

Sykes, R. B., D. P. Bonner, K. Bush, N. H. Georgopapadakou, and J. S. Wells. 1981. Monobactams-monocyclic β-lactam antibiotics produced by bacteria. J. Antimicrob. Chemother.8(Suppl. E):1-16.

10.1038/291489a0

10.1021/jm049903j

10.1021/ja00134a003

10.1021/bi0502700

10.1128/AAC.39.11.2591

10.1021/bi700792a

10.1074/jbc.M603222200

10.1128/AAC.01293-06

10.1021/ja042984o

10.1016/S1074-5521(98)90632-9

10.1074/jbc.M104742200

10.1021/bi060990m

10.1074/jbc.M003802200

10.1016/S1074-5521(02)00211-9

10.1021/ja056124z

10.1128/AAC.50.2.498-504.2006

Tzouvelekis, L. S., and R. A. Bonomo. 1999. SHV-type β-lactamases. Curr. Pharm. Des.5:847-864.

10.1128/AAC.41.2.475

10.1093/infdis/167.2.448

Urban, C., J. J. Rahal, and B. Luft. 1991. Effect of a β-lactamase inhibitor, tazobactam, on growth and penicillin-binding proteins of Borrelia burgdorferi. FEMS Microbiol. Lett.66:113-116.

10.1021/bi981210f

10.1128/AAC.42.7.1542

10.1093/jac/30.4.449

10.1021/jm060021p

10.1021/jm049680x

10.1021/jm070643q

10.1128/AAC.45.8.2215-2223.2001

10.1128/CMR.18.2.306-325.2005

10.1016/S0040-4020(97)00404-3

10.1016/0960-894X(96)00453-2

10.1093/jac/dki482

10.1021/bi034242y

10.1002/prot.10058

10.1074/jbc.M204212200

10.1021/bi990356r

10.1016/S1367-5931(99)00017-4

10.1128/AAC.48.12.4589-4596.2004

Antimicrob. Agents Chemother. 2009

10.1021/jm980343w

10.1128/AAC.27.5.876

10.1021/bi990030i

Williams, H., A. King, K. Shannon, and I. Phillips. 1988. Amoxycillin/clavulanate resistant Escherichia coli. Lanceti:304-305.

10.1093/clinids/24.3.494

10.1128/AAC.38.3.494

10.1093/jac/36.6.927

10.1021/ja072370u

10.1074/jbc.M512517200

10.1021/jm701031n

10.1016/S0021-9258(19)61429-8

10.1128/AAC.34.5.755

10.1128/AAC.47.12.3881-3889.2003

10.1016/j.jmb.2009.04.028

10.1021/bi00130a016

10.1021/ja00030a070

10.1111/j.1574-6976.2007.00095.x

10.1074/jbc.M406157200